Catalyst Event

Regeneron Pharmaceuticals Inc (REGN) · Earnings Release

From KEDI Nvidia Fixed Tech100 Index (KNVDT100)

4/29/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Reported Q1 2026 financial results, beating analyst expectations. Revenue increased 19% YoY to $3.6 billion, and non-GAAP EPS was $9.47. A new $3.0 billion share repurchase program was also authorized. High importance assigned due to significant earnings beat and buyback, estimated to impact price by ≥10% scheduled.

Korean Translation

2026년 1분기 재무 실적 발표, 분석가 예상 상회함. 매출은 전년 동기 대비 19% 증가한 36억 달러, 비-GAAP 주당순이익(EPS)은 9.47달러를 기록함. 또한 30억 달러 규모의 신규 자사주 매입 프로그램을 승인함. 실적 호조 및 자사주 매입으로 10% 이상의 주가 영향이 예상됨.

Related Recent Events

View Full Timeline